Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience Life Science Investing
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+ for Prostate Cancer Biotech Investing
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology Annual Meeting Life Science Investing
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights Life Science Investing
Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Pharmaceutical Investing
Gilead to Present New Data Advancing Care in PBC and Viral Hepatitis at EASL 2026 Life Science Investing
BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study Biotech Investing
BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update Life Science Investing
European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors Pharmaceutical Investing
